Form 4 for TMDX TransMedics Group, Inc.
Accepted 2024-03-12 00:00:00 ET · period of report 2024-03-08 · accession 0000950170-24-030277 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-03-12 | 2024-03-08 | TMDX | Khayal Tamer I | Chief Commercial Off | M - OptEx | $16.14 | +100 | 26.6K | +0.4% | +$1,614 |
| DMT | 2024-03-12 | 2024-03-08 | TMDX | Khayal Tamer I | Chief Commercial Off | S - Sale+OE | $87.80 | -1,417 | 26.5K | -5% | -$124.4K |
| DT | 2024-03-12 | 2024-03-08 | TMDX | Khayal Tamer I | Chief Commercial Off | M - OptEx | $0.00 | -100 | 15.6K | -0.6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-08 | M | A | 100 | $16.14 | 26,602 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-08 | S | D | 1,317 | $87.63 | 25,185 | D | — | — | |
| 3 | Common | Common Stock | 2024-03-08 | S | D | 100 | $90.04 | 26,502 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2024-03-08 | M | D | 100 | $0.00 | 15,646 | D | $16.14 · — to 2030-02-27 | 100 Common Stock | (F3) The option is fully vested. |